Imaging Challenges in Diagnosing Triple-Negative Breast Cancer

被引:11
|
作者
Schopp, Jennifer G. [1 ]
Polat, Dogan S. [1 ]
Arjmandi, Firouzeh [1 ]
Hayes, Jody C. [1 ]
Ahn, Richard W. [1 ]
Sullivan, Kirbi [1 ]
Sahoo, Sunati [2 ]
Porembka, Jessica H. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd,MC 8896, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, 5323 Harry Hines Blvd,MC 8896, Dallas, TX 75390 USA
关键词
NEOADJUVANT CHEMOTHERAPY; MOLECULAR PORTRAITS; FEATURES; SURVIVAL; TUMORS; RECURRENCE; PHENOTYPE; BASAL;
D O I
10.1148/rg.230027
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Triple-negative breast cancer (TNBC) refers to a heterogeneous group of carcinomas that have more aggressive biologic features, faster growth, and a propensity for early distant metastasis and recurrence compared with other breast cancer subtypes. Due to the aggressiveness and rapid growth of TNBCs, there are specific imaging challenges associated with their timely and accurate diagnosis. TNBCs commonly manifest initially as circumscribed masses and therefore lack the typical features of a primary breast malignancy, such as irregular shape, spiculated margins, and desmoplastic reaction. Given the potential for misinterpretation, review of the multimodality imaging appearances of TNBCs is important for guiding the radiologist in distinguishing TNBCs from benign conditions. Rather than manifesting as a screening-detected cancer, TNBC typically appears clinically as a palpable area of concern that most commonly corresponds to a discrete mass at mammography, US, and MRI. The combination of circumscribed margins and hypoechoic to anechoic echogenicity may lead to TNBC being misinterpreted as a benign fibroadenoma or cyst. Therefore, careful mammographic and sonographic evaluation with US image optimization can help avoid misinterpretation. Radiologists should recognize the characteristics of TNBCs that can mimic benign entities, as well as the subtle features of TNBCs that should raise concern for malignancy and aid in timely and accurate diagnosis.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges
    Wei, Ya-Nan
    Yan, Chun-Yan
    Zhao, Meng-Lu
    Zhao, Xi -He
    MOLECULAR THERAPY ONCOLYTICS, 2023, 31
  • [32] Epigenetic Therapies in Triple-Negative Breast Cancer: Concepts, Visions, and Challenges
    Lehmann, Ulrich
    CANCERS, 2024, 16 (12)
  • [33] Research advances and new challenges in overcoming triple-negative breast cancer
    Zong, Yu
    Pegram, Mark
    CANCER DRUG RESISTANCE, 2021, 4 (03) : 517 - 542
  • [34] Theranostics for Triple-Negative Breast Cancer
    Choi, Hyeryeon
    Kim, Kwangsoon
    DIAGNOSTICS, 2023, 13 (02)
  • [35] Advanced Triple-Negative Breast Cancer
    Patel, Grisma
    Prince, Alison
    Harries, Mark
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [36] What is triple-negative breast cancer?
    Irvin, William J., Jr.
    Carey, Lisa A.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2799 - 2805
  • [37] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01): : 59 - 66
  • [38] Pembrolizumab in Triple-Negative Breast Cancer
    Altundag, Kadri
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15): : 1435 - 1436
  • [39] A Review of Triple-Negative Breast Cancer
    Ismail-Khan, Roohi
    Bui, Marilyn M.
    CANCER CONTROL, 2010, 17 (03) : 173 - 176
  • [40] Triple-negative breast cancer: an update
    Boolbol, Susan K.
    Cate, Sarah P.
    BREAST CANCER MANAGEMENT, 2014, 3 (02) : 127 - 129